Dipharma Francis S.r.l. completes acquisition of Kalexsyn, Inc.

12:49 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a worl...

Other Sources for this Article

Paola Clerici
Communication Manager
Dipharma Francis S.r.l.
Tel. +39 0238228320


More From BioPortfolio on "Dipharma Francis S.r.l. completes acquisition of Kalexsyn, Inc."

Quick Search


Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...